Abu Dhabi, UAE – The Department of Health – Abu Dhabi, the regulatory body for the healthcare sector in the emirate, launched Abu Dhabi Biobank. Which is an integrated platform that links biological samples with genetic, clinical and lifestyle data. This enhances the success of early diagnosis of diseases and enables improved personal care. This step represents another achievement within Abu Dhabi’s ambitious plans to transform the model of disease detection, prevention and treatment.
strategic partnership
The launch of the biobank comes as part of a strategic partnership between the Department of Health – Abu Dhabi and M42. To reflect Abu Dhabi’s efforts to transform healthcare delivery, moving from treating the disease to identifying early danger signs, improving diagnostic accuracy, and designing the necessary procedures that are appropriate for each individual’s condition.
The biobank is located in Masdar City and is considered an advanced and zero-emission facility. It has a capacity exceeding 100,000 umbilical cord blood samples and up to five million biological samples. Which establishes one of the most advanced and diverse sources of health data in the region. And most importantly. The Bank introduces a new model of care, in which life sciences, data and clinical practice come together on a large population scale to improve outcomes across the health system as a whole.
Key qualitative capabilities
The launch of the biobank offers key qualitative capabilities, including an integrated human biobank that links biological samples with clinical, longitudinal, genetic and lifestyle data on a large scale. In addition to a national eye bank, it enhances local tissue culture capabilities and reduces dependence on imported tissues from abroad.
Abu Dhabi Biobank is designed to serve as an integrated dynamic platform that continues to integrate biosamples with actual health data. To support prevention efforts and scientific research. Based on a population base of more than 200 nationalities, the Bank enables insights that reflect the actual diversity of societies. Which contributes to enhancing the efficiency and reliability of medical innovations.
